Lexeo Therapeutics, Inc. · NASDAQ:LXEO

Citadel Advisors LLC reported a 7.40% stake in Lexeo Therapeutics, Inc. (Schedule 13G/A)

Event Dec 31, 2025 · Filed Feb 17, 2026

Citadel Advisors LLC reported a 7.40% stake in Lexeo Therapeutics, Inc., 5,498,219 shares, as a passive investor on Dec 31, 2025. Filed Feb 17, 2026 (Schedule 13G/A).

Stake
7.40%
Shares
5,498,219
Intent
Passive
What changed
Stake changed
Filed together
7 holders

The filing in full

HolderStakeShares
Citadel Advisors LLC7.20%5,405,269
Citadel Advisors Holdings LP7.20%5,405,269
Citadel GP LLC7.20%5,405,269
Citadel Securities LLC0%6,600
Citadel Securities Group LP0.10%92,950
Citadel Securities GP LLC0.10%92,950
Kenneth Griffin7.40%5,498,219

Source

View original at SEC

Related